BMC oral health · 2026
Diabetes is associated with elevated mortality, stroke, and osteoradionecrosis in squamous cell carcinomas of the head and neck: a systematic review and meta-analysis.
СтатьяСистематический обзорМетаанализНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bencze Bulcsú, Cavalcante Bianca Golzio Navarro, Róna Virág, Szabó Bence, Wenning Alexander Schulze, Hermann Péter, Varga Gábor, Németh Orsolya, Hegyi Péter, Végh Dániel
Аннотация
BACKGROUND: Diabetes mellitus has been associated with an increased incidence and potentially with a worse prognosis of squamous cell carcinomas due to chronic inflammation, oxidative stress, and metabolic reprogramming, which promote tumor growth and therapy resistance. Furthermore, it impairs immune response and posttreatment healing, potentially leading to higher complication rates.
METHODS: The study protocol was preregistered (CRD42025634653). An electronic search was conducted in MEDLINE, Embase, and Cochrane. Studies on patients with squamous cell carcinomas were included to compare survival metrics and complication rates with and without diabetes. Hazard ratios, odds ratios, and mean differences were extracted. A random-effects model was used, with subgroups based on cancer location.
RESULTS: 63 predominantly retrospective studies met the inclusion criteria, with a population of 138,000 individuals. The meta-analysis found statistically significant differences in disease-specific (HR = 1.47 [1.11-1.96]; I2 = 60%), overall (HR = 1.31 [1.23-1.39]; I2 = 4%), and disease-free survival (HR = 1.58 [1.12-2.24]; I2 = 58%); the subgroup analysis revealed that diabetes significantly affected oral and oropharyngeal subsites. Posttreatment stroke (HR = 2.11 [1.15-3.87]; I2 = 70%) and osteoradionecrosis rates (HR = 2.2 [1.38-3.53]; I2 = 11%) were significantly elevated.
CONCLUSION: Diabetes is associated with worse disease-specific survival in oral and oropharyngeal subtypes and a twofold higher risk of osteoradionecrosis development in patients with squamous cell carcinoma. Weaker evidence suggests that overall survival and stroke development rate are also affected by diabetes mellitus.
METHODS: The study protocol was preregistered (CRD42025634653). An electronic search was conducted in MEDLINE, Embase, and Cochrane. Studies on patients with squamous cell carcinomas were included to compare survival metrics and complication rates with and without diabetes. Hazard ratios, odds ratios, and mean differences were extracted. A random-effects model was used, with subgroups based on cancer location.
RESULTS: 63 predominantly retrospective studies met the inclusion criteria, with a population of 138,000 individuals. The meta-analysis found statistically significant differences in disease-specific (HR = 1.47 [1.11-1.96]; I2 = 60%), overall (HR = 1.31 [1.23-1.39]; I2 = 4%), and disease-free survival (HR = 1.58 [1.12-2.24]; I2 = 58%); the subgroup analysis revealed that diabetes significantly affected oral and oropharyngeal subsites. Posttreatment stroke (HR = 2.11 [1.15-3.87]; I2 = 70%) and osteoradionecrosis rates (HR = 2.2 [1.38-3.53]; I2 = 11%) were significantly elevated.
CONCLUSION: Diabetes is associated with worse disease-specific survival in oral and oropharyngeal subtypes and a twofold higher risk of osteoradionecrosis development in patients with squamous cell carcinoma. Weaker evidence suggests that overall survival and stroke development rate are also affected by diabetes mellitus.